Health Canada has announced that it has lifted the temporary precautionary suspension on all Novartis influenza vaccine products in Canada.

After extensive consultation with Novartis, and public health and regulatory officials in Italy and Switzerland, as well as its own product assessments, Health Canada has determined that there are no safety concerns with any Novartis vaccine products in Canada or British Columbia.

With this release for use, all Fluad and Agriflu products currently distributed across health authorities in B.C. will be put back into use in public influenza vaccine campaigns. That campaign is now underway throughout the province. Novartis products represent about 30 per cent of the provincial vaccine supply.

graphic from wikipedia